These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Conditional mouse models to study developmental and pathophysiological gene function in muscle. Wamhoff BR; Sinha S; Owens GK Handb Exp Pharmacol; 2007; (178):441-68. PubMed ID: 17203666 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner. Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005 [TBL] [Abstract][Full Text] [Related]
13. Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer. Inamoto T; Shah JB; Kamat AM Urol Oncol; 2009; 27(6):585-91. PubMed ID: 19162510 [TBL] [Abstract][Full Text] [Related]
14. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention. Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742 [TBL] [Abstract][Full Text] [Related]
16. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats. Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C; Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932 [TBL] [Abstract][Full Text] [Related]
17. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk. Tönjes A; Stumvoll M Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457 [TBL] [Abstract][Full Text] [Related]
18. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Gavériaux-Ruff C; Kieffer BL Pharmacol Ther; 2007 Mar; 113(3):619-34. PubMed ID: 17289150 [TBL] [Abstract][Full Text] [Related]
19. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Zieleniak A; Wójcik M; Woźniak LA Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859 [TBL] [Abstract][Full Text] [Related]
20. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity. Allen T; Zhang F; Moodie SA; Clemens LE; Smith A; Gregoire F; Bell A; Muscat GE; Gustafson TA Diabetes; 2006 Sep; 55(9):2523-33. PubMed ID: 16936200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]